Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

INTRODUCTION: The human epidermal growth factor receptor 2 (HER2) is a validated therapeutic target in breast cancer. Heterodimerization of HER2 with other HER family members results in enhanced tyrosine phosphorylation and activation of signal transduction pathways. HER2 overexpression increases th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Quanri, Yuan, Linda X, Boulbes, Delphine, Baek, Jong Min, Wang, Ying Nai, Gomez-Cabello, Daniel, Hawke, David H, Yeung, Sai Ching, Lee, Mong Hong, Hortobagyi, Gabriel N, Hung, Mien Chie, Esteva, Francisco J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046439/
https://www.ncbi.nlm.nih.gov/pubmed/21080941
http://dx.doi.org/10.1186/bcr2777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046439/
https://www.ncbi.nlm.nih.gov/pubmed/21080941
http://dx.doi.org/10.1186/bcr2777

Ejemplares similares